Abstract: An acute kidney injury predicting system and a method thereof are proposed. A processor reads the data to be tested, the detection data, the machine learning algorithm and the risk probability comparison table from a main memory. The processor trains the detection data according to the machine learning algorithm to generate an acute kidney injury prediction model, and inputs the data to be tested into the acute kidney injury prediction model to generate an acute kidney injury characteristic risk probability and a data sequence table. The data sequence table lists the data to be tested in sequence according to a proportion of each of the data to be tested in the acute kidney injury characteristics. The processor selects one of the medical treatment data from the risk probability comparison table according to the acute kidney injury characteristic risk probability.

Abstract: There is provided a smoke detector including a first light source, a second light source surface, a light sensor and a processor. The light sensor receives reflected light when the first light source and the second light source emit light, and generates a first detection signal corresponding to light emission of the first light source and a second detection signal corresponding to light emission of the second light source. The processor distinguishes smoke and floating particles according to a similarity between the first detection signal and the second detection signal.

Abstract: Provided herein is a plasma generating device for medical treatment and sanitizing purposes which comprises a control unit and a plasma generator connecting to the control unit. The plasma generator comprises a plasma tube having a first end and a second end; a first dielectric layer disposed on the inner surface of the plasma tube; a first electrode disposed on the first dielectric layer; a second dielectric layer disposed on the first electrode; a second electrode disposed on the second dielectric layer; and a plasma nozzle disposed on the bottom cover on the second end of the plasma tube.

Abstract: Provided herein is a plasma generating device for medical treatment and sanitizing purposes which comprises a control unit and a plasma generator connecting to the control unit. The plasma generator comprises a plasma tube having a first end and a second end; a first dielectric layer disposed on the inner surface of the plasma tube; a first electrode disposed on the first dielectric layer; a second dielectric layer disposed on the first electrode; a second electrode disposed on the second dielectric layer; and a plasma nozzle disposed on the bottom cover on the second end of the plasma tube.

Abstract: A wireless control sensing device is disclosed. The sensing device has an instruction receiving unit and at least one sensing unit. The instruction receiving unit wirelessly receives an instruction signal, and then the sensing unit adjusts a sensing parameter of the sensing unit according to the received instruction signal.

Abstract: A wireless headphone, such as a Bluetooth wireless headphone, includes a Bluetooth wireless module and a modulated module. The Bluetooth wireless module is configured to receive a Bluetooth communication signal and the modulated module is configured to receive a FM audio signal. The Bluetooth wireless module and the modulated module are electrically connected.

Abstract: An oscillating circuit is constructed by a capacitor in an integrated circuit and an external conductive wire. The external conductive wire is used as an inductor and the inductance thereof is determined by a diameter and a length of the conductive wire. In addition, a conductive film is connected to the conductive wire and ground. Output frequency of the oscillating circuit can be tuned by cutting the conductive film to adjust the capacitance and the inductance of the oscillating circuit.

Abstract: A complex comprised of the HBcAg and an albumin or an unprocessed structural protein from a positive stranded RNA virus. Pursuant to such complexing, the antigenicity of the HBcAg is enhanced when compared to HBcAg alone, in terms of both or either affinity or specificity. This complexed HBcAg can be recognized by the immune system, which produces antibodies that have a high specificity and affinity for the complexed HBcAg, although such antibodies typically do also bind the uncomplexed antigen to a lower specificity and affinity. Also, methods and devices using the same.

Abstract: The unprocessed polyprotein initially translated from the genome of a positive-stranded RNA virus contains epitopic configurations that are not retained in the processed proteins. The structural protein region, in particular, loses an epitopic configuration upon processing at the cleavage site between the genomic region encoding the core protein and the genomic region encoding the protein adjacent the core protein, such as the envelope protein in HCV. Compositions, methods and assays relating to the diagnosis and detection of the presence of the positive-stranded RNA virus, or antibodies to the positive-stranded RNA virus, in a sample. Compositions and methods for the induction of immune responses in, and vaccination of, an animal. Combination of the unprocessed core region with a non-structural protein (such as an NS5 or an unprocessed NS3-NS4 fusion from HCV).

Abstract: The invention relates to a DNA molecule, a polypeptide expressed by the molecule, their use in diagnosis and their methods of production. More particularly, the invention relates to a diagnostic DNA molecule, a diagnostic protein, diagnostic antibodies and protective antigen and antibodies for hepatitis C virus (HCV). The DNA molecule disclosed herein is characterized by the DNA molecule derived from the genome of an HCV, and codes for a polypeptide having the antigenicity of an HCV core antigen protein. The polypeptide may be used in the detection of HCV.

Abstract: The invention relates to a polypeptide expressed by a DNA molecule, its use in diagnosis and its methods of production. The polypeptide disclosed herein is encoded by a DNA molecule derived from the genome of an HCV, and comprises a hepatitis C virus (HCV) core antigen protein fused to a part of an envelope region of a hepatitis C virus (HCV) protein The polypeptide may be used in the detection of HCV.